Insights from Experts at Mayo Clinic on Translating Evidence to Clinical Practice - Episode 2
Shared insight on the GMMG-HD7 study, which utilized a frontline isatuximab-containing quadruplet regimen in patients with newly diagnosed multiple myeloma.